Vesalius Biocapital Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
70
- Portfolio
-
20
- Exits
-
22
Vesalius Biocapital Partners General Information
Company Description
Founded in 2007, Vesalius Biocapital Partners is a venture capital firm based in Strassen, Luxembourg. The firm seeks to make investments in the life science, therapeutic, medical device, diagnostic, and biotechnology sectors.
Business Details
Website
www.vesaliusbiocapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 1B rue Thomas Edison
- Strassen, 1445
- Luxembourg
Vesalius Biocapital Partners Investments & Acquisitions (70)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| RougeTx | 06-Oct-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Nutrium | 16-Sep-2025 | Other Healthcare Technology Systems | Generating Revenue | |||
| Rejuvenate Biomed | 07-Aug-2025 | Drug Discovery | Generating Revenue | |||
| ENYO Pharma | 12-Jun-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| HepaRegenix | 15-Apr-2025 | Drug Discovery | Generating Revenue | |||
| Inflammatix | 12-Sep-2024 | Diagnostic Equipment | Product Development | |||
| Caresyntax | 15-Aug-2024 | Decision/Risk Analysis | Generating Revenue | |||
| Catalym | 16-Jul-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Memo Therapeutics | 07-May-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| inHEART | 06-May-2024 | Later Stage VC | Decision/Risk Analysis | Generating Revenue |
Vesalius Biocapital Partners Exits (22)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Memo Therapeutics | 22-Jul-2026 | Merger/Acquisition | |
| DEARHealth | 01-Apr-2025 | ||
| Humedics | 08-Dec-2022 | ||
| SkylineDX | 21-Dec-2021 | ||
| Forendo Pharma | 13-Dec-2021 | ||
| Apitope | 21-Sep-2021 | ||
| Trod Medical | 27-Aug-2021 | ||
| Softhale | 31-Mar-2021 | ||
| Ventaleon | 01-Jan-2020 | Out of Business | |
| Bienca | 01-Sep-2019 | Out of Business |
Vesalius Biocapital Partners Investments by Industry, Year, and Region
Vesalius Biocapital Partners Co-Investors (107)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BioGeneration Ventures | 3 |
|
|
||
| Iberis Capital |
|
|
|||
| Kurma Partners |
|
|
|||
| Swisscanto Holding |
|
|
|||
| Wallonie Entreprendre |
|
|
Vesalius Biocapital Partners FAQs
-
What is Vesalius Biocapital Partners?
Founded in 2007, Vesalius Biocapital Partners is a venture capital firm based in Strassen, Luxembourg.
-
When was Vesalius Biocapital Partners founded?
Vesalius Biocapital Partners was founded in 2007.
-
Where is Vesalius Biocapital Partners headquartered?
Vesalius Biocapital Partners is headquartered in Strassen, Luxembourg.
-
What is Vesalius Biocapital Partners's total asset value?
Vesalius Biocapital Partners has around in total assets under management.
-
How many investments has Vesalius Biocapital Partners made?
Vesalius Biocapital Partners has made 70 investments.
-
What has Vesalius Biocapital Partners invested in?
Vesalius Biocapital Partners has made numerous investments in companies like RougeTx, Nutrium, and Rejuvenate Biomed within the Drug Discovery and Healthcare Technology Systems industries.
-
What has Vesalius Biocapital Partners invested in recently?
Vesalius Biocapital Partners's latest investment was on 06-Oct-2026 in RougeTx, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process